Concepedia

Laura Jiménez

LJ

16

Publications

1.9K

Citations

13

H-Index

2010

Active since

Affiliations

Institut d'Investigació Biomédica de Bellvitge(Current)

Institut Català d'Oncologia

Bellvitge University Hospital

Universitat de Barcelona

Instituto de Salud Carlos III

Laura Jiménez is an author at Institut d'Investigació Biomédica de Bellvitge specializing in medicine, oncology, and cancer research.

ORCID

Top concepts

Publications per year

2010–2023

16

Publications

16

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2021 · 516 citations · Full text

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2022 · 382 citations · Full text

, , +3

Changing aetiology, clinical features, antimicrobial resistance, and outcomes of bloodstream infection in neutropenic cancer patients

Carlota Gudiol, Marta Bodro, Antonella F. Simonetti et al. · Clinical Microbiology and Infection · 2012 · 297 citations · Full text

, , +12

Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2021 · 289 citations · Full text

Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2023 · 126 citations · Full text

Rows per page

1–5 of 16